Wednesday 29 November 2017

Leading Pharma Franchise Company in Punjab


Biophar Group Ltd has been working on bringing about a revolution in the field of medicine by making medicines available to people at affordable price, whilst ensuring that quality standards are met. The company’s style of conducting business makes them to attain a strong brand positioning in the market.

The top pharma PCD has a wide range of product portfolio to cater to its customers. The company provides various products to its customers from injectables, Capsules, Tablets, softgel Capsules, Dry Syrup, Syrup, facewash, Ointments, Eye Drops to  Lotions , Ear Drops, Oral Liquid (Syrup & Suspension), External Liquids, Creams, betalactum Products, General Products, nutraceuticals, Soaps, Shampoo, Oral Sachets & Powders and  External Powders. The company is into manufacturing of vast range of products and delivers supreme quality to its customers.

The Pharma Franchise is growing at an increasing pace and has a strong clientele across the country. So as to outreach itself for market penetration , the company is constantly spreading itself  at the most unrepresented areas through appointment of new distributors, franchise, distributors, sole distributors, PCD franchise on the monopoly  basis. The company believes that since Drugs and Pharmaceutical industry has major role in the economic development of a country, therefore it is very critical for all such industries to follow GMP (good manufacturing practices) and strong validation processes for quality manufacturing. The company lays a strong emphasis on the fact that existence of a well-defined and strong pharmaceutical industry so as to promote and sustain research and developmental efforts and initiatives in an economy along with manufacturing quality medicines at economical prices. For a country to become a developed economy it is imperative to raise the health status of individuals and the society for a positive contribution towards the economic growth and regional development of a country.

No comments:

Post a Comment